Imprimis Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
15,629.40
8,361.80
2,835.00
9,053.00
4,219.00
Total Accounts Receivable
-
81.30
840.00
2,921.00
1,624.00
Inventories
-
372.70
1,412.00
1,841.00
2,249.00
Other Current Assets
105.10
240.40
786.00
938.00
714.00
Total Current Assets
15,734.50
9,056.20
5,873.00
14,753.00
8,806.00
Net Property, Plant & Equipment
26.90
243.40
2,657.00
7,295.00
6,215.00
Total Investments and Advances
-
-
-
-
3,507.00
Long-Term Note Receivable
-
-
-
-
302.00
Intangible Assets
-
942.60
5,601.00
5,199.00
5,087.00
Total Assets
15,761.40
10,242.20
14,131.00
27,247.00
23,917.00
ST Debt & Current Portion LT Debt
-
24.10
21.00
4,431.00
598.00
Accounts Payable
261.90
786.70
3,407.00
3,538.00
3,885.00
Other Current Liabilities
388.70
749.50
1,946.00
1,936.00
1,291.00
Total Current Liabilities
650.60
1,560.30
5,374.00
9,905.00
5,774.00
Long-Term Debt
-
19.00
8,337.00
9,255.00
14,728.00
Provision for Risks & Charges
-
483.20
-
-
-
Deferred Taxes
-
-
1,047.00
936.00
-
Other Liabilities
-
29.70
758.00
719.00
800.00
Total Liabilities
650.60
2,092.10
15,516.00
20,815.00
21,302.00
Common Equity (Total)
15,110.70
8,150.20
1,385.00
6,432.00
2,615.00
Total Shareholders' Equity
15,110.70
8,150.20
1,385.00
6,432.00
2,615.00
Total Equity
15,110.70
8,150.20
1,385.00
6,432.00
2,615.00
Liabilities & Shareholders' Equity
15,761.40
10,242.20
14,131.00
27,247.00
23,917.00
About Imprimis Pharmaceuticals
View Profile
